The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome-Reference-Cited by-同舟云学术

The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome

Published:2015-11-09 Issue:12 Volume:47 Page:1465-1470
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

da Silva Almeida Ana Carolina,Abate Francesco,Khiabanian Hossein,Martinez-Escala Estela,Guitart Joan,Tensen Cornelis P,Vermeer Maarten H,Rabadan Raul,Ferrando Adolfo,Palomero Teresa

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.3442.pdf

Reference33 articles.

1. Querfeld, C., Rosen, S.T., Guitart, J. & Kuzel, T.M. The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy. Curr. Opin. Hematol. 12, 273–278 (2005).

2. Wilcox, R.A. Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 89, 837–851 (2014).

3. Agar, N.S. et al. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J. Clin. Oncol. 28, 4730–4739 (2010).

4. Cristofoletti, C. et al. Comprehensive analysis of PTEN status in Sézary syndrome. Blood 122, 3511–3520 (2013).

5. Mao, X. et al. Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-cell lymphomas suggesting impaired cell cycle control in disease pathogenesis. J. Invest. Dermatol. 126, 1388–1395 (2006).

Cited by 321 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral T-cell lymphoma: From biology to practice to the future;Cancer Treatment Reviews;2024-09

2. Die fünfte Auflage der WHO‐Klassifikation – Was ist neu für kutane Lymphome?;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-09

3. The skin microbiome stratifies patients with cutaneous T cell lymphoma and determines event-free survival;npj Biofilms and Microbiomes;2024-08-29

4. Kinases Inhibitors as New Therapeutic Opportunities in Cutaneous T-Cell Lymphoma;Kinases and Phosphatases;2024-08-28

5. The fifth edition of the WHO‐Classification – what is new for cutaneous lymphomas?;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-08